• 1
    Elenkov IJ, Wilder RL, Chrousos GP et al. The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 585638.
  • 2
    Fish EW, Shahrokh D, Bagot R et al. Epigenetic programming of stress responses through variations in maternal care. Ann N Y Acad Sci 2004; 1036: 16780.
  • 3
    Esler MD, Goulston KJ. Levels of anxiety in colonic disorders. N Engl J Med 1973; 288: 1620.
  • 4
    Heim C, Newport DJ, Heit S et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. J Am Med Assoc 2000; 284: 5927.
  • 5
    Dinan TG, Quigley EM, Ahmed SM et al. Hypothalmic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential marker? Gastroenterology 2006; 130: 30411.
  • 6
    Elsenbruch S, Orr WC. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol 2001; 96: 4606.
    Direct Link:
  • 7
    Elsenbruch S, Holtmann G, Oezcan D et al. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol 2004; 99: 70310.
    Direct Link:
  • 8
    Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1999; 42: 8459.
  • 9
    Dickhaus B, Mayer EA, Firooz N et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol 2003; 98: 13543.
    Direct Link:
  • 10
    Heitkemper M, Jarrett M, Cain K et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol 1996; 91: 90613.
  • 11
    Heitkemper M, Jarrett M, Cain KC et al. Autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci 2001; 46: 127684.
  • 12
    Cain KC, Jarrett ME, Burr RL et al. Heart rate variability is related to pain severity and predominant bowel pattern in women with irritable bowel syndrome. Neurogastroenterol Motil 2007; 19: 1108.
  • 13
    Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 177883.
  • 14
    Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693702.
  • 15
    Martinez V, Taché Y. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 2006; 12: 407188.
  • 16
    Dunlop SP, Jenkins D, Neal KR et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 16519.
  • 17
    Bohmelt AH, Nater UM, Franke S et al. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005; 67: 28894.
  • 18
    Posserud I, Agerforz P, Ekman R et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004; 53: 11028.
  • 19
    Elsenbruch S, Lovallo WR, Orr WC. Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome. Psychosom Med 2001; 63: 80510.
  • 20
    Heim C, Newport DJ, Bonsall R et al. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatr 2001; 158: 57581.
  • 21
    Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: II437.
  • 22
    Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia, a report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 16072.
  • 23
    Sperber AD, Atzmon Y, Neumann L et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999; 94: 35416.
    Direct Link:
  • 24
    Whitehead WE, Palsson O, Jones KR. Systemic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 114056.
  • 25
    Talley NJ, Phillips SF, Wiltgen CM et al. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 145679.
  • 26
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 27
    Spitzer RL, Williams JBW, Gibbon M et al. Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press, 1990.
  • 28
    Green BL. The Trauma History Questionnaire (THQ). In: StammBH, ed. Measurement of Stress, Trauma, and Adaptation. Lutherville: Sidran Press, 1996: 3669.
  • 29
    Gracely RH, McGrath P, Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 1976; 5: 1929.
  • 30
    Posener JA, Charles D, Veldhuis JD et al. Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder. Psychoneuroendocrinology 2004; 29: 112937.
  • 31
    Guo W, Wang Y, Brown MB. A signal extraction approach to modeling hormone time series with pulses and a changing baseline. J Am Stat Assoc 1999; 94: 74656.
  • 32
    Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 2001; 25: 26776.
  • 33
    Crofford LJ, Young EA, Engleberg NC et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004; 18: 31425.
  • 34
    McGowan I, Elliott J, Fuerst M et al. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 2004; 37: 122836.
  • 35
    Yehuda R, Yang RK, Buchsbaum MS et al. Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD. Psychoneuroendocrinology 2006; 31: 44751.
  • 36
    Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. Endocrinol Metab Clin North Am 1992; 21: 83358.
  • 37
    Yehuda R, Giller EL Jr, Levengood RA et al. Hypothalamic-Pituitary-Adrenal Functioning in Post-Traumatic Stress Disorder: Expanding the Concept of the Stress Response Spectrum. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to Post-Traumatic Stress Disorder. Philadelphia: Lippincott-Raven Publishers, 1995: 35166.
  • 38
    Klerman EB, Goldenberg DL, Brown EN et al. Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 2001; 86: 10349.
  • 39
    Munakata J, Naliboff B, Harraf F et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997; 112: 5563.
  • 40
    Videlock EJ, Yuan PQ, Taché Y et al. Stress-induced cortisol response and colonic mucosal CRF-1 mRNA receptor expression correlate with symptoms of chronic stress and quality of life in irritable bowel syndrome (IBS). Gastroenterology 2007; 132: A-72.
  • 41
    Dinan TG, O’Keane V, O’Boyle C et al. A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatr Scand 1991; 84: 268.
  • 42
    Sagami Y, Shimada Y, Tayama J et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004; 53: 95864.
  • 43
    Quigley EM, McSharry J, O’Mahoney L et al. Mucosal cytokine imbalance in irritable bowel syndrome (IBS). Am J Gastroenterol 2007; 102(Suppl.): 632.
  • 44
    Barbara G, Wang B, Grundy D et al. Mast cells are increased in the colonic mucosa of patients with irritable bowel syndrome and excite visceral sensory pathways. Gastroenterology 2005; 128: A-626.
  • 45
    O’Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 54151.
  • 46
    Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 91320.
  • 47
    Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav Immun 2007; 21: 73645.
  • 48
    Nielsen OH, Vainer B, Madsen SM et al. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000; 95: 35967.
  • 49
    Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 2006; 1069: 6276.
  • 50
    Mastorakos G, Ilias I. Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress. Ann N Y Acad Sci 2006; 1088: 37381.
  • 51
    Gwee KA, Collins SM, Read NW et al. Increased rectal mucosal expression of interleukin 1á in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 5236.
  • 52
    Caballero T, Nogueras F, Medina MT et al. Intraepithelial and lamina propria leucocyte subsets in inflammatory bowel disease: an immunohistochemical study of colon and rectal biopsy specimens. J Clin Pathol 1995; 48: 7438.
  • 53
    Tracey KJ. The inflammatory reflex. Nature 2002; 420: 8539.